Current challenges of diabetes and metabolic disorders in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current challenges of diabetes and metabolic disorders in China

Published:2023-03-28 Issue:S1 Volume:25 Page:3-4
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Ji Linong¹^ORCID

Affiliation:

1. Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.15048

Reference10 articles.

1. Prevalence of Diabetes among Men and Women in China

2. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study

3. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

4. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

5. Effects of glucagon‐like peptide‐1 receptor agonists on major coronary events in patients with type 2 diabetes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and application prospect of adipose-derived stem cell secretome in diabetes foot ulcers healing;Stem Cell Research & Therapy;2024-09-04

2. Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide;Nutrients;2024-07-20

3. Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum–Mitochondria miscommunication in the liver of HFD mice;Biomedicine & Pharmacotherapy;2024-06

4. Inquiry lipaseoring the mechanism of pancreatic lipase inhibition by isovitexin based on multispectral method and enzyme inhibition assay;Luminescence;2024-05

5. Engineering novel scaffolds for specific HDAC11 inhibitors against metabolic diseases exploiting deep learning, virtual screening, and molecular dynamics simulations;International Journal of Biological Macromolecules;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3